{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Dr. Robert Feig, a retina specialist in Brooklyn and the Bronx, says he wants to save patients and Medicare money by treating eye diseases with a drug that costs $50 a dose, rather than one that costs $2,000 a dose. But three recent incidents around the country in which a total of 21 patients lost some or all vision in the affected eye after injections of the less expensive drug have made him fearful of a malpractice lawsuit, should something similar happen at his practice.", "headline": {"main": "Risk Reports Chill the Use of a Cheaper Eye Drug"}, "abstract": "Rise of eye infections from use of Avastin, some leading to blindness, has caused many physicians to choose more expensive Lucentis for treating wet form macular degeneration in elderly patients; photos (M)", "print_page": "1", "word_count": 1011, "_id": "4fd2b9598eb7c8105d8af6cb", "snippet": "Dr. Robert Feig, a retina specialist in Brooklyn and the Bronx, says he wants to save patients and Medicare money by treating eye diseases with a drug that costs $50 a dose, rather than one that costs $2,000 a dose.     But three recent incidents...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9B07EFDE1F31F936A35753C1A9679D8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "INFECTIONS"}, {"name": "subject", "value": "MACULAR DEGENERATION"}, {"name": "subject", "value": "ELDERLY"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "LUCENTIS (DRUG)"}, {"name": "subject", "value": "AVASTIN (DRUG)"}, {"name": "subject", "value": "EYES AND EYESIGHT"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Andrew", "rank": 1, "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "article", "pub_date": "2011-10-05T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": null, "headline": {"main": "Doctors Grow Wary of Avastin for Eye Treatment", "kicker": "Prescriptions Blog", "print_headline": "Risk Reports Chill the Use of a Cheaper Eye Drug"}, "abstract": "A spate of infections, leaving some patients blind, has caused some physicians to choose the more expensive Lucentis for eye disease in the elderly.", "print_page": null, "word_count": "995", "_id": "54f3d8f279881075cd221fbd", "snippet": "A spate of infections, leaving some patients blind, has caused some physicians to choose the more expensive Lucentis for eye disease in the elderly.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://prescriptions.blogs.nytimes.com/2011/10/04/doctors-grow-wary-of-avastin-for-eye-treatment/", "multimedia": [], "subsection_name": "Money &amp; Policy", "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "blogpost", "pub_date": "2011-10-04T09:51:25Z", "section_name": "Health"}, {"type_of_material": "Blog", "blog": [], "news_desk": null, "lead_paragraph": "Dr. Robert Feig, a retina specialist in Brooklyn and the Bronx, says he wants to save patients and Medicare money by treating eye diseases with a drug that costs $50 a dose, rather than one that costs $2,000 a dose.", "headline": {"main": "Doctors Grow Wary of Avastin for Eye Treatment", "kicker": "Prescriptions"}, "abstract": "A spate of infections, leaving some patients blind, has caused some physicians to choose the more expensive Lucentis for eye disease in the elderly.", "print_page": null, "word_count": 970, "_id": "4fd3a1e58eb7c8105d8e92dc", "snippet": "A spate of infections, leaving some patients blind, has caused some physicians to choose the more expensive Lucentis for eye disease in the elderly.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://prescriptions.blogs.nytimes.com/2011/10/04/doctors-grow-wary-of-avastin-for-eye-treatment/", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Eyes and Eyesight", "name": "subject", "rank": "4"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "3"}, {"value": "Avastin (Drug)", "name": "subject", "rank": "2"}, {"value": "Macular Degeneration", "name": "subject", "rank": "5"}, {"value": "News", "name": "type_of_material", "rank": "1"}, {"value": "Medicare", "name": "subject", "rank": "6"}, {"value": "Genentech Inc", "name": "organizations", "rank": "7"}, {"value": "Veterans Affairs Department", "name": "organizations", "rank": "8"}, {"value": "Lucentis", "name": "unknown", "rank": "9"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Andrew", "lastname": "POLLACK"}], "original": "By ANDREW POLLACK"}, "document_type": "blogpost", "pub_date": "2011-10-04T09:51:25Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "The National Center for Health Statistics said fewer than one in 10 deaths was followed by an autopsy in 2007, compared with one in five in 1972.", "headline": {"main": "Autopsies Waning, Except on Television", "kicker": "Vital Statistics", "print_headline": "Autopsies Waning, Except on Television", "content_kicker": "Vital Statistics"}, "abstract": null, "print_page": "7", "word_count": "320", "_id": "54019d4d79881068a19488b5", "snippet": "The National Center for Health Statistics said fewer than one in 10 deaths was followed by an autopsy in 2007, compared with one in five in 1972.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/10/04/health/04stat.html", "multimedia": [{"subtype": "wide", "url": "images/2011/10/04/health/04stath/04stath-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2011/10/04/health/04stath/04stath-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Autopsies", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Deaths (Fatalities)", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Nicholas", "lastname": "BAKALAR"}], "original": "By NICHOLAS BAKALAR"}, "document_type": "article", "pub_date": "2011-10-04T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Researchers report that throat cancers caused by the human papillomavirus, transmitted during oral sex, have increased significantly in the United States.", "headline": {"seo": "Study Cites Increase in Throat Cancers Caused by HPV", "main": "Study Cites Increase in Cancers From HPV", "print_headline": "Study Cites Increase In Cancers From HPV"}, "abstract": null, "print_page": "5", "word_count": "683", "_id": "5401b42c79881068a1948a6c", "snippet": "Researchers report that throat cancers caused by the human papillomavirus, transmitted during oral sex, have increased significantly in the United States.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/10/04/health/research/04hpv.html", "multimedia": [], "subsection_name": "Research", "keywords": [{"value": "Human Papilloma Virus (HPV)", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Head and Neck Cancer", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Oral Cancer", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Sexually Transmitted Diseases", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Denise", "lastname": "GRADY"}], "original": "By DENISE GRADY"}, "document_type": "article", "pub_date": "2011-10-04T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Scientists are at work on shots that could one day release people from the grip of substance abuse.", "headline": {"seo": "A Vaccine Against Smoking or Cocaine? It\u2019s in the Works.", "main": "An Addiction Vaccine, Tantalizingly Close", "print_headline": "An Addiction Vaccine, Tantalizingly Close"}, "abstract": null, "print_page": "1", "word_count": "1686", "_id": "5401b3e879881068a1948a66", "snippet": "Scientists are at work on shots that could one day release people from the grip of substance abuse.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/10/04/health/04vaccine.html", "multimedia": [{"subtype": "xlarge", "url": "images/2011/10/04/science/04VACC_SPAN/04VACC_SPAN-articleLarge.jpg", "height": 360, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2011/10/04/science/04VACC_SPAN/04VACC_SPAN-articleLarge.jpg", "xlargeheight": "360"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2011/10/04/science/04VACC_SPAN/04VACC_SPAN-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2011/10/04/science/04VACC_SPAN/04VACC_SPAN-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Vaccination and Immunization", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Drug Abuse and Traffic", "is_major": "N", "rank": "2", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "4", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Douglas", "lastname": "QUENQUA"}], "original": "By DOUGLAS QUENQUA"}, "document_type": "article", "pub_date": "2011-10-04T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Science", "lead_paragraph": "Researchers found that an increased risk of death in young adulthood was independent of sex, birth order, maternal age, parental education or marital status, and birth weight.", "headline": {"seo": "Higher Risk of Death for Preemies Returns in Young Adulthood", "main": "Patterns: Risks for Preemies Resurface Years Later", "kicker": "Vital Signs", "print_headline": "Patterns: Dangers for Preemies Persist Years Later", "content_kicker": "Vital Signs"}, "abstract": null, "print_page": "6", "word_count": "227", "_id": "5401b2b779881068a1948a4a", "snippet": "Researchers found that an increased risk of death in young adulthood was independent of sex, birth order, maternal age, parental education or marital status, and birth weight.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2011/10/04/health/research/04patterns.html", "multimedia": [], "subsection_name": "Research", "keywords": [{"value": "Premature Babies", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "2", "name": "subject"}], "byline": {"contributor": "", "person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Nicholas", "lastname": "BAKALAR"}], "original": "By NICHOLAS BAKALAR"}, "document_type": "article", "pub_date": "2011-10-04T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 7, "offset": 0, "time": 45}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}